These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26378019)

  • 21. Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake.
    Fuereder T; Wanek T; Pflegerl P; Jaeger-Lansky A; Hoeflmayer D; Strommer S; Kuntner C; Wrba F; Werzowa J; Hejna M; Müller M; Langer O; Wacheck V
    Clin Cancer Res; 2011 Aug; 17(16):5322-32. PubMed ID: 21712451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proanthocyanidins from the American Cranberry (Vaccinium macrocarpon) inhibit matrix metalloproteinase-2 and matrix metalloproteinase-9 activity in human prostate cancer cells via alterations in multiple cellular signalling pathways.
    Déziel BA; Patel K; Neto C; Gottschall-Pass K; Hurta RA
    J Cell Biochem; 2010 Oct; 111(3):742-54. PubMed ID: 20626034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cranberry proanthocyanidins mediate growth arrest of lung cancer cells through modulation of gene expression and rapid induction of apoptosis.
    Kresty LA; Howell AB; Baird M
    Molecules; 2011 Mar; 16(3):2375-90. PubMed ID: 21399574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
    Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH
    Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.
    Penna I; Molla A; Grazia G; Cleris L; Nicolini G; Perrone F; Picciani B; Del Vecchio M; de Braud F; Mortarini R; Anichini A
    Oncotarget; 2016 Jan; 7(4):3947-65. PubMed ID: 26678033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin E succinate induces apoptosis via the PI3K/AKT signaling pathways in EC109 esophageal cancer cells.
    Yang P; Zhao J; Hou L; Yang L; Wu K; Zhang L
    Mol Med Rep; 2016 Aug; 14(2):1531-7. PubMed ID: 27357907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.
    Gedaly R; Angulo P; Chen C; Creasy KT; Spear BT; Hundley J; Daily MF; Shah M; Evers BM
    Anticancer Res; 2012 Jul; 32(7):2531-6. PubMed ID: 22753710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice.
    Dai C; Zhang B; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wang J; Guo K; Ma W; Xing B; Lian W; Xiao J; Cai F; Zhang H; Wang R
    Endocrinology; 2013 Mar; 154(3):1247-59. PubMed ID: 23384836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.
    Martinelli E; Troiani T; D'Aiuto E; Morgillo F; Vitagliano D; Capasso A; Costantino S; Ciuffreda LP; Merolla F; Vecchione L; De Vriendt V; Tejpar S; Nappi A; Sforza V; Martini G; Berrino L; De Palma R; Ciardiello F
    Int J Cancer; 2013 Nov; 133(9):2089-101. PubMed ID: 23629727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monascuspiloin induces apoptosis and autophagic cell death in human prostate cancer cells via the Akt and AMPK signaling pathways.
    Chen RJ; Hung CM; Chen YL; Wu MD; Yuan GF; Wang YJ
    J Agric Food Chem; 2012 Jul; 60(29):7185-93. PubMed ID: 22738037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of the PI3K/AKT/mTOR signaling cascade and induction of apoptosis in HL-60 cells by an essential oil from Monarda citriodora.
    Pathania AS; Guru SK; Verma MK; Sharma C; Abdullah ST; Malik F; Chandra S; Katoch M; Bhushan S
    Food Chem Toxicol; 2013 Dec; 62():246-54. PubMed ID: 23994707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of MAPK and PI3K/AKT signaling pathways on Malabaricone-A induced cytotoxicity in U937, a histiocytic lymphoma cell line.
    Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
    Int Immunopharmacol; 2016 Oct; 39():34-40. PubMed ID: 27398613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway.
    Shen Z; Xu L; Li J; Zhang N
    Med Sci Monit; 2017 May; 23():2096-2103. PubMed ID: 28463955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma.
    Zhuang H; Bai J; Chang JY; Yuan Z; Wang P
    Oncotarget; 2016 Dec; 7(51):84688-84694. PubMed ID: 27713162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121.
    Peng Y; Zhou Y; Cheng L; Hu D; Zhou X; Wang Z; Xie C; Zhou F
    Biochem Biophys Res Commun; 2015 Sep; 465(1):137-44. PubMed ID: 26235881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K-mTOR pathway in pancreatic adenocarcinoma.
    Mirzoeva OK; Hann B; Hom YK; Debnath J; Aftab D; Shokat K; Korn WM
    J Mol Med (Berl); 2011 Sep; 89(9):877-89. PubMed ID: 21678117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention.
    Kresty LA; Clarke J; Ezell K; Exum A; Howell AB; Guettouche T
    J Carcinog; 2011; 10():34. PubMed ID: 22279419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway.
    Xu HY; Chen ZW; Hou JC; Du FX; Liu JC
    Oncol Rep; 2013 Jan; 29(1):212-8. PubMed ID: 23129237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cranberry phytochemical extract inhibits SGC-7901 cell growth and human tumor xenografts in Balb/c nu/nu mice.
    Liu M; Lin LQ; Song BB; Wang LF; Zhang CP; Zhao JL; Liu JR
    J Agric Food Chem; 2009 Jan; 57(2):762-8. PubMed ID: 19108687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.